Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by SARGEN GREGORY, Director. Director active across 2 companies, notably Avid Bioservices, Inc.. In total, 9 disclosures have been published. Split: 0 buy · 3 sells. Total volume traded: €130k. History available since 11 April 2023. The latest transaction was disclosed on 11 April 2023 (Cession). Regulator: SEC (Form 4). All data is openly available.
Gregory Sargen is a Director at Avid Bioservices, Inc. As a board member, he contributes to the governance of the company and strategic decision-making. His experience in the biopharmaceutical sector is an asset for Avid Bioservices, which specializes in the manufacturing of biological products.